Exhibit 24.1
POWER OF ATTORNEY
Each
of the undersigned officers and directors of Navidea
Biopharmaceuticals, Inc., a Delaware corporation (the "Company"),
hereby appoints Michael M. Goldberg and Jed A. Latkin, or either of
them, as his or her true and lawful attorneys-in-fact, with power
to act without the other, as his or her true and lawful
attorney-in-fact, in his or her name and on his or her behalf, and
in any and all capacities stated below, to sign and to cause to be
filed with the Securities and Exchange Commission (the
"Commission"), the Company's Registration Statement on Form S-8
(the "Registration Statement") to register under the Securities Act
of 1933, as amended, 500,000 shares of Common Stock, $.001 par
value, of the Company to be to be issued to the Navidea
Biopharmaceuticals, Inc. 401(k) Plan and Trust (the
“Plan”) or its beneficiaries as employer matching
contributions, and such other number of shares as may be issued
under the anti-dilution provision of the Plan, and any and all
amendments, including post-effective amendments, to the
Registration Statement, hereby granting unto such
attorneys-in-fact, and to each of them, full power and authority to
do and perform in the name of and on behalf of the undersigned, in
any and all such capacities, every act and thing whatsoever
necessary to be done in and about the premises as fully as the
undersigned could or might do in person, hereby granting to each
such attorney-in-fact full power of substitution and revocation,
and hereby ratifying all that any such attorney-in-fact or his
substitute may do by virtue hereof.
IN
WITNESS WHEREOF, the undersigned have signed these presents this
5th day of May, 2017.
|
Signature
|
|
Title
|
|
|
|
|
|
/s/
Michael M. Goldberg
|
|
President,
Chief Executive Officer and Director
|
|
Michael
M. Goldberg, M.D.
|
|
(principal
executive officer)
|
|
|
|
|
|
/s/ Jed
A. Latkin
|
|
Chief
Operating Officer & Chief Financial Officer
|
|
Jed A.
Latkin
|
|
(principal
financial officer and principal accounting officer)
|
|
|
|
|
|
/s/
Eric K. Rowinsky
|
|
Chairman
of the Board of Directors
|
|
Eric K.
Rowinsky, M.D.
|
|
|
|
|
|
|
|
/s/
Anthony S. Fiorino
|
|
Director
|
|
Anthony
S. Fiorino, M.D., Ph.D.
|
|
|
|
|
|
|
|
/s/
Mark I. Greene
|
|
Director
|
|
Mark I.
Greene, M.D., Ph.D., FRCP
|
|
|
|
|
|
|
|
/s/ Y.
Michael Rice
|
|
Director
|
|
Y.
Michael Rice
|
|
|